000 01118 a2200325 4500
005 20250513083719.0
264 0 _c19960208
008 199602s 0 0 eng d
022 _a0041-1345
040 _aNLM
_beng
_cNLM
100 1 _aKneteman, N M
245 0 0 _aBeneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients.
_h[electronic resource]
260 _bTransplantation proceedings
_cDec 1995
300 _a3213 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCyclosporine
_xadverse effects
650 0 4 _aDogs
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aInsulin
_xblood
650 0 4 _aIslets of Langerhans Transplantation
_xadverse effects
650 0 4 _aPolyenes
_xadverse effects
650 0 4 _aSirolimus
650 0 4 _aTime Factors
650 0 4 _aTransplantation, Autologous
700 1 _aLakey, J R
700 1 _aWagner, T
700 1 _aFinegood, D
773 0 _tTransplantation proceedings
_gvol. 27
_gno. 6
_gp. 3213
999 _c8539020
_d8539020